Day 100 PET Scan Positivity Predicts for Worse Survival in Lymphoma Patients Given Allogeneic Peripheral Blood Stem Cells After Non-Myeloablative Conditioning

被引：0
|
作者：
Jaspers, Aurelie [1 ]
Fosse, Pacome [1 ]
Withofs, Nadia [1 ]
Lejeune, Marie [1 ]
Willems, Evelyne [1 ]
Hafraoui, Kaoutar [1 ]
Hustinx, Roland [1 ]
Baron, Frederic [2 ]
Beguin, Yves
机构：
[1] CHU Liege, Liege, Belgium
[2] Univ Liege, GIGA Res, Liege, Belgium
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1777 / 1778
页数：2
相关论文
共 50 条
  • [21] Is there a CD34+threshold of infused cells that influences the clinical outcome after non-myeloablative allogeneic peripheral blood stem cell transplantation?
    Michallet, AS
    Nicolini, F
    Lé, Q
    Thiébaut, A
    Audigier-Valette, C
    Thomas, X
    Troncy, J
    Vigouroux, C
    Bourgeot, JP
    Eljafaari, A
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S136 - S136
  • [22] Early recovery of host T cells predicts primary graft rejection following non-myeloablative conditioning allogeneic hematopoietic stem cell transplantation
    Koyama, M.
    Hashimoto, D.
    Kamezaki, K.
    Numata, A.
    Sakoda, Y.
    Aoyama, K.
    Takenaka, K.
    Miyamoto, T.
    Harada, N.
    Nagafuji, K.
    Akashi, K.
    Tanimoto, M.
    Harada, M.
    Teshima, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 127 - 127
  • [23] Impact of Cotransplantation of Mesenchymal Stem Cells on Lung Function After Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Following Non-Myeloablative Conditioning
    Moermans, Catherine
    Lechanteur, Chantal
    Baudoux, Etienne
    Giet, Olivier
    Henket, Monique
    Seidel, Laurence
    Lejeune, Marie
    Willems, Evelyne
    Baron, Frederic
    Louis, Renaud
    Beguin, Yves
    TRANSPLANTATION, 2014, 98 (03) : 348 - 353
  • [24] Secondary allogeneic peripheral blood stem cell transplantation (ALLO PBSCT) using a non-myeloablative conditioning regimen for malignant lymphoma (ML) patients (Pts) who relapsed after autologous bone marrow transplantation (ABMT).
    Nagler, A
    Or, R
    Naparstek, E
    Varadi, G
    Slavin, S
    BLOOD, 1997, 90 (10) : 2449 - 2449
  • [25] Massive immune hemolysis after non-myeloablative allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility
    Noborio, K
    Muroi, K
    Izumi, T
    Toshima, M
    Kawano-Yamamoto, C
    Otsuki, T
    Nagai, T
    Komatsu, N
    Ozawa, K
    LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 357 - 359
  • [26] Non-myeloablative conditioning regimen in allogeneic peripheral blood stem transplantation (ALLOPBSCT) for high risk hematologic malignancies (HM)-preliminary results.
    Vaz, CP
    Campos, A
    Campilho, F
    Carvalhais, A
    Roncón, S
    Martinho, A
    Avila, A
    Pimentel, P
    BLOOD, 1999, 94 (10) : 363B - 363B
  • [27] Non-myeloablative conditioning and peripheral blood stem cell (PBSC) allografting for poor prognosis patients (pts) with hematological malignancies.
    Hansz, J
    Gozdzik, J
    Gil, L
    Drozdowska, D
    Sawinski, K
    Kozlowska-Skrzypczak, M
    BLOOD, 2000, 96 (11) : 355B - 355B
  • [28] Chimerism analysis in peripheral blood buffy coat and T-cell fractions after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).
    Theil, K
    Warshawsky, I
    Tubbs, R
    Shadrach, B
    Serafino, S
    Cerankosky, L
    Johnston, G
    Rybicki, L
    Kuczkowski, E
    Jarvis, J
    Curtis, J
    Serafin, M
    Sands, K
    Bolwell, BJ
    BLOOD, 2001, 98 (11) : 188A - 189A
  • [29] High anti-tumor activity of natural killer cells after non-myeloablative conditioning and allogeneic stem cell transplantation.
    Fischer, Lars
    Penack, Olaf
    Stroux, Andrea
    Gentilini, Chiara
    Thiel, Eckhard
    Uharek, Lutz
    BLOOD, 2006, 108 (11) : 376B - 376B
  • [30] High rates of infectious complications associated with HLA-mismatched or unrelated donor allogeneic peripheral blood stem cell transplantation after non-myeloablative conditioning for patients with multiple myeloma.
    Lee, CK
    Barlogie, B
    Morris, CL
    Badros, AZ
    van Rhee, F
    Cottler-Fox, MH
    Anaissie, EJ
    Zangari, M
    Fassas, A
    Thertulien, R
    Muwalla, F
    Tricot, G
    BLOOD, 2002, 100 (11) : 859A - 859A
12345